New research reveals that people who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass far faster than those who end conventional diet and exercise programs.
Research printed in a major medical journal shows that while obese people frequently drop a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.
"Users purchasing such treatments need to be aware of the danger of fast weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment mass within about one and a half years.
Weighing Therapies
The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the outcomes of the injectable medications with other pills.
The team point out that people who shed pounds through diet and exercise typically experience a less rapid weight regain—around 100 grams monthly—after stopping.
Understanding the Fast Rebound
Experts suggest the way of the drugs explains the heightened weight return.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone concentrations far above than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication results in appetite is unsuppressed, making binge eating a significant risk."
A Chronic Condition?
Health authorities suggest the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians say that, due to the significant potential of weight regain, the treatment should be considered ongoing.
This view is echoed by pharmaceutical companies, who say that the results "emphasize the chronic character of excess weight," comparing it to managing diseases like diabetes.
Patient Testimonies
People who have come off the medication explain a intense return of appetite.
"I experienced something flipping and I was suddenly ravenous," recalled one woman.
This difficulty is worsened if patients have not established sustainable dietary or behavioural changes during treatment.
Growing Adoption
Recent estimates indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Use is more common among females than men.
- The middle-aged age group shows the highest usage rates.
- Many access the medications through private healthcare rather than public health services.
In conclusion, researchers stress that while these medications are powerful tools for weight loss, they are not a standalone fix and lasting health benefits likely depends on ongoing lifestyle support.
